Sasigarn A. Bowden

869 total citations
36 papers, 545 citations indexed

About

Sasigarn A. Bowden is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Sasigarn A. Bowden has authored 36 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Sasigarn A. Bowden's work include Adrenal Hormones and Disorders (9 papers), Metabolism and Genetic Disorders (5 papers) and Hormonal Regulation and Hypertension (5 papers). Sasigarn A. Bowden is often cited by papers focused on Adrenal Hormones and Disorders (9 papers), Metabolism and Genetic Disorders (5 papers) and Hormonal Regulation and Hypertension (5 papers). Sasigarn A. Bowden collaborates with scholars based in United States, Canada and China. Sasigarn A. Bowden's co-authors include John D. Mahan, Robert P. Hoffman, Brian L. Foster, Roxane Carr, Renee Robinson, John R. Mytinger, Brent H. Adler, Philip Zeitler, Kathi Kinnett and Anne M. Connolly and has published in prestigious journals such as SHILAP Revista de lepidopterología, PEDIATRICS and Critical Care Medicine.

In The Last Decade

Sasigarn A. Bowden

34 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sasigarn A. Bowden United States 14 247 185 153 117 82 36 545
Vrinda Saraff United Kingdom 14 110 0.4× 146 0.8× 84 0.5× 79 0.7× 103 1.3× 39 489
Olcay Evliyaoğlu Türkiye 14 325 1.3× 168 0.9× 150 1.0× 163 1.4× 49 0.6× 80 667
S M de Muinck Keizer-Schrama Netherlands 15 247 1.0× 185 1.0× 104 0.7× 184 1.6× 34 0.4× 19 606
Şükran Poyrazoğlu Türkiye 18 333 1.3× 244 1.3× 133 0.9× 287 2.5× 45 0.5× 84 794
C M Francucci Italy 13 108 0.4× 65 0.4× 80 0.5× 132 1.1× 39 0.5× 20 474
Tobias Schmidt Germany 16 166 0.7× 45 0.2× 130 0.8× 66 0.6× 186 2.3× 39 596
Kathryn Dahir United States 17 441 1.8× 84 0.5× 103 0.7× 167 1.4× 262 3.2× 56 745
Murray B. Gordon United States 20 764 3.1× 73 0.4× 357 2.3× 119 1.0× 71 0.9× 59 1.2k
Bülent Hacıhamdioğlu Türkiye 15 138 0.6× 148 0.8× 80 0.5× 181 1.5× 23 0.3× 54 564
P W Lu Australia 8 156 0.6× 183 1.0× 142 0.9× 154 1.3× 36 0.4× 10 792

Countries citing papers authored by Sasigarn A. Bowden

Since Specialization
Citations

This map shows the geographic impact of Sasigarn A. Bowden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sasigarn A. Bowden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sasigarn A. Bowden more than expected).

Fields of papers citing papers by Sasigarn A. Bowden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sasigarn A. Bowden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sasigarn A. Bowden. The network helps show where Sasigarn A. Bowden may publish in the future.

Co-authorship network of co-authors of Sasigarn A. Bowden

This figure shows the co-authorship network connecting the top 25 collaborators of Sasigarn A. Bowden. A scholar is included among the top collaborators of Sasigarn A. Bowden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sasigarn A. Bowden. Sasigarn A. Bowden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bowden, Sasigarn A., et al.. (2025). 266: ECMO IN PEDIATRIC HHS/DKA AND MALIGNANT HYPERTHERMIA-LIKE SYNDROME. Critical Care Medicine. 53(1).
2.
Grover, Monica, Ambika P. Ashraf, Sasigarn A. Bowden, et al.. (2024). Invited Mini Review Metabolic Bone Disease of Prematurity: Overview and Practice Recommendations. Hormone Research in Paediatrics. 98(1). 1–11. 6 indexed citations
3.
Bowden, Sasigarn A.. (2023). Current Screening Strategies for the Diagnosis of Adrenal Insufficiency in Children. Pediatric Health Medicine and Therapeutics. Volume 14. 117–130. 3 indexed citations
4.
Bowden, Sasigarn A., et al.. (2022). Treatment Practices and Confidence in the Management of Pediatric Metabolic Bone Disorders. Hormone Research in Paediatrics. 95(4). 354–362. 1 indexed citations
5.
Bowden, Sasigarn A., et al.. (2022). Validation of automated bone age analysis from hand radiographs in a North American pediatric population. Pediatric Radiology. 52(7). 1347–1355. 8 indexed citations
6.
Zhou, Danlei, Michael Rudnicki, Gilbert T. Chua, et al.. (2021). Human Complement C4B Allotypes and Deficiencies in Selected Cases With Autoimmune Diseases. Frontiers in Immunology. 12. 739430–739430. 16 indexed citations
7.
Bowden, Sasigarn A., et al.. (2021). Novel function of adrenocorticotropic hormone in the stimulation of vascular endothelial growth factor release in healthy children and adolescents: a proof-of-concept study. Annals of Pediatric Endocrinology & Metabolism. 26(1). 46–52. 1 indexed citations
8.
Bowden, Sasigarn A., et al.. (2020). Pediatric Type 2 Diabetes Mellitus. StatPearls. 1 indexed citations
9.
Bowden, Sasigarn A. & Brian L. Foster. (2018). Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy. Drug Design Development and Therapy. Volume 12. 3147–3161. 33 indexed citations
10.
Bowden, Sasigarn A., et al.. (2018). Pediatric Adrenal Insufficiency: Diagnosis, Management, and New Therapies. International Journal of Pediatrics. 2018. 1–8. 38 indexed citations
11.
Bowden, Sasigarn A. & Brent H. Adler. (2017). Asfotase alfa treatment for 1 year in a 16 year-old male with severe childhood hypophosphatasia. Osteoporosis International. 29(2). 511–515. 10 indexed citations
12.
Bowden, Sasigarn A. & John D. Mahan. (2017). Zoledronic acid in pediatric metabolic bone disorders. Translational Pediatrics. 6(4). 256–268. 23 indexed citations
13.
Mytinger, John R. & Sasigarn A. Bowden. (2015). Adrenal Function Testing Following Hormone Therapy for Infantile Spasms: Case Series and Review of Literature. Frontiers in Neurology. 6. 259–259. 13 indexed citations
14.
Thompson, Michael D., et al.. (2015). Severe hyponatraemia with absence of hyperkalaemia in rapidly progressive Addison's disease. BMJ Case Reports. 2015. bcr2015209903–bcr2015209903. 9 indexed citations
15.
Bowden, Sasigarn A., et al.. (2015). Cervicofacial subcutaneous emphysema in a 4-year-old boy. BMJ Case Reports. 2015. bcr2015210223–bcr2015210223. 6 indexed citations
16.
Ayoob, Rose, et al.. (2014). Beneficial effects of intravenous pamidronate treatment in children with osteogenesis imperfecta under 24 months of age. Journal of Bone and Mineral Metabolism. 33(5). 560–568. 15 indexed citations
17.
Bowden, Sasigarn A., Hiren P. Patel, Allan Beebe, & Kim L. McBride. (2013). Successful Medical Therapy for Hypophosphatemic Rickets due to Mitochondrial Complex I Deficiency Induced de Toni-Debré-Fanconi Syndrome. SHILAP Revista de lepidopterología. 2013. 1–5. 4 indexed citations
18.
19.
Bowden, Sasigarn A. & Robert P. Hoffman. (2008). Triple diabetes: coexistence of type 1 diabetes mellitus and a novel mutation in the gene responsible for MODY3 in an overweight adolescent. Pediatric Diabetes. 9(2). 162–164. 17 indexed citations
20.
Bowden, Sasigarn A., Juan F. Sotos, Constantine A. Stratakis, & Robert J. Weil. (2007). Successful Treatment of an Invasive Growth Hormone-Secreting Pituitary Macroadenoma in an 8 Year-old Boy. Journal of Pediatric Endocrinology and Metabolism. 20(5). 643–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vrinda Saraff Breakdown of academic impact, for papers by Olcay Evliyaoğlu Breakdown of academic impact, for papers by S M de Muinck Keizer-Schrama Breakdown of academic impact, for papers by Şükran Poyrazoğlu Breakdown of academic impact, for papers by C M Francucci Breakdown of academic impact, for papers by Tobias Schmidt Breakdown of academic impact, for papers by Kathryn Dahir Breakdown of academic impact, for papers by Murray B. Gordon Breakdown of academic impact, for papers by Bülent Hacıhamdioğlu Breakdown of academic impact, for papers by P W Lu
Rankless by CCL
2026